GlassScriptPhysician profile
Amanda Ramsey
NPI 1386006757
$2,093.31
in general payments reported to CMS, 2019-2025
17 companies · $600 in 2025
The $600 reported for 2025 was more than what 78% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $242 · 2022: $267 · 2023: $435 · 2024: $550 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,584.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $781.01 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $481.58 | 2021-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $317.73 | 2022-2025 | |
| Kowa Pharmaceuticals America, INC. | $78.24 | 2022-2025 | Zoryve, Livalo, Seglentis |
| Lilly USA, LLC | $70.80 | 2023-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $67.76 | 2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $56.37 | 2021-2024 | Trelegy Ellipta |
| Pfizer INC. | $49.70 | 2021-2023 | |
| Gilead Sciences, INC. | $30.58 | 2021 | |
| Verity Pharmaceuticals INC. | $28.98 | 2025 | Tlando |
| Tolmar, INC. | $27.71 | 2023-2024 | |
| Adlon Therapeutics L.P. | $21.88 | 2021 | |
| Supernus Pharmaceuticals, INC. | $21.80 | 2022 | |
| Amgen INC. | $18.03 | 2024 | Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.10 | 2024 | Xifaxan, Trulance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $13.96 | 2021 | |
| Eisai INC. | $12.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Ramsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.